Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Infect Control Hosp Epidemiol ; 45(4): 526-529, 2024 Apr.
Article in English | MEDLINE | ID: mdl-37700531

ABSTRACT

We investigated whether and how infection prevention programs monitor for health disparities as part of healthcare-associated infection (HAI) surveillance through a survey of healthcare epidemiology leaders. Most facilities are not assessing for disparities in HAI rates. Professional society and national guidance should focus on addressing this gap.


Subject(s)
Cross Infection , Humans , Cross Infection/epidemiology , Cross Infection/prevention & control , Surveys and Questionnaires , Health Facilities , Delivery of Health Care , Health Inequities , Infection Control
2.
Infect Control Hosp Epidemiol ; 44(12): 2059-2061, 2023 Dec.
Article in English | MEDLINE | ID: mdl-37308466

ABSTRACT

Two independent temporal-spatial clusters of hospital-onset Rhizopus infections were evaluated using whole-genome sequencing (WGS). Phylogenetic analysis confirmed that isolates within each cluster were unrelated despite epidemiological suspicion of outbreaks. The ITS1 region alone was insufficient for accurate analysis. WGS has utility for rapid rule-out of suspected nosocomial Rhizopus outbreaks.


Subject(s)
Genome, Bacterial , Rhizopus , Humans , Rhizopus/genetics , Phylogeny , Hospitals , Disease Outbreaks
3.
Infect Control Hosp Epidemiol ; 44(1): 40-46, 2023 01.
Article in English | MEDLINE | ID: mdl-35311638

ABSTRACT

BACKGROUND: Methicillin-resistant Staphylococcus aureus (MRSA) is an important pathogen in neonatal intensive care units (NICU) that confers significant morbidity and mortality. OBJECTIVE: Improving our understanding of MRSA transmission dynamics, especially among high-risk patients, is an infection prevention priority. METHODS: We investigated a cluster of clinical MRSA cases in the NICU using a combination of epidemiologic review and whole-genome sequencing (WGS) of isolates from clinical and surveillance cultures obtained from patients and healthcare personnel (HCP). RESULTS: Phylogenetic analysis identified 2 genetically distinct phylogenetic clades and revealed multiple silent-transmission events between HCP and infants. The predominant outbreak strain harbored multiple virulence factors. Epidemiologic investigation and genomic analysis identified a HCP colonized with the dominant MRSA outbreak strain who cared for most NICU patients who were infected or colonized with the same strain, including 1 NICU patient with severe infection 7 months before the described outbreak. These results guided implementation of infection prevention interventions that prevented further transmission events. CONCLUSIONS: Silent transmission of MRSA between HCP and NICU patients likely contributed to a NICU outbreak involving a virulent MRSA strain. WGS enabled data-driven decision making to inform implementation of infection control policies that mitigated the outbreak. Prospective WGS coupled with epidemiologic analysis can be used to detect transmission events and prompt early implementation of control strategies.


Subject(s)
Cross Infection , Methicillin-Resistant Staphylococcus aureus , Staphylococcal Infections , Infant, Newborn , Infant , Humans , Methicillin-Resistant Staphylococcus aureus/genetics , Intensive Care Units, Neonatal , Cross Infection/epidemiology , Staphylococcal Infections/prevention & control , Virulence/genetics , Prospective Studies , Phylogeny , Disease Outbreaks/prevention & control , Infection Control/methods , Genomics
8.
AORN J ; 113(2): 147-164, 2021 02.
Article in English | MEDLINE | ID: mdl-33534156

ABSTRACT

The evolution of SARS-CoV-2 from a zoonotic virus to a novel human pathogen resulted in the coronavirus disease 2019 (COVID-19) global pandemic. Health care delivery and infection prevention and control recommendations continue to evolve to protect the safety of health care personnel, patients, and visitors while researchers and policymakers learn more about SARS-CoV-2 and COVID-19. The perioperative setting is unique in that it exposes clinicians and personnel to increased risks through the invasive nature of surgical care. Using the Centers for Disease Control and Prevention's Hierarchy of Controls as a model, this article presents risk mitigation strategies for preventing the transmission of COVID-19 in the perioperative environment. The goals are to identify and eliminate potential exposure to SARS-CoV-2 when surgery is necessary for patients who are suspected or confirmed to have COVID-19 or who have an unknown infection status.


Subject(s)
COVID-19/transmission , Infectious Disease Transmission, Patient-to-Professional/prevention & control , Perioperative Nursing , SARS-CoV-2 , COVID-19/nursing , Humans , Infection Control
SELECTION OF CITATIONS
SEARCH DETAIL
...